Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
0.7500
+0.1000 (15.38%)
Jul 17, 2025, 4:08 PM HKT
HKG:1643 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
214.07 | 344.08 | 399.66 | 360.7 | 308.69 | Upgrade | |
Revenue Growth (YoY) | -37.78% | -13.91% | 10.80% | 16.85% | 41.11% | Upgrade |
Cost of Revenue | 158.87 | 239.9 | 228.87 | 202.27 | 171.83 | Upgrade |
Gross Profit | 55.2 | 104.18 | 170.79 | 158.43 | 136.86 | Upgrade |
Selling, General & Admin | 31.37 | 35.81 | 41.69 | 44.79 | 32.17 | Upgrade |
Operating Expenses | 31.37 | 35.81 | 41.69 | 44.79 | 32.17 | Upgrade |
Operating Income | 23.83 | 68.37 | 129.1 | 113.64 | 104.69 | Upgrade |
Interest Expense | -0 | -0.01 | -0.01 | -0.07 | -0.25 | Upgrade |
Interest & Investment Income | 0.77 | 0.91 | 0.68 | 0.42 | 0.14 | Upgrade |
Currency Exchange Gain (Loss) | -1.26 | -1.23 | -5.91 | 0.04 | - | Upgrade |
Other Non Operating Income (Expenses) | 0.07 | 0.27 | 0.42 | 0.2 | -14.1 | Upgrade |
EBT Excluding Unusual Items | 23.41 | 68.31 | 124.26 | 114.22 | 90.48 | Upgrade |
Gain (Loss) on Sale of Assets | -8.59 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | 0.06 | - | - | Upgrade |
Pretax Income | 14.82 | 68.31 | 124.32 | 114.22 | 90.48 | Upgrade |
Income Tax Expense | 5.15 | 19.51 | 36.5 | 32.45 | 26.9 | Upgrade |
Net Income | 9.67 | 48.8 | 87.83 | 81.78 | 63.58 | Upgrade |
Net Income to Common | 9.67 | 48.8 | 87.83 | 81.78 | 63.58 | Upgrade |
Net Income Growth | -80.18% | -44.44% | 7.40% | 28.63% | 37.50% | Upgrade |
Shares Outstanding (Basic) | 600 | 600 | 600 | 594 | 450 | Upgrade |
Shares Outstanding (Diluted) | 600 | 600 | 600 | 594 | 450 | Upgrade |
Shares Change (YoY) | - | - | 1.04% | 31.96% | - | Upgrade |
EPS (Basic) | 0.02 | 0.08 | 0.15 | 0.14 | 0.14 | Upgrade |
EPS (Diluted) | 0.02 | 0.08 | 0.15 | 0.14 | 0.14 | Upgrade |
EPS Growth | -80.18% | -44.44% | 6.30% | -2.53% | 37.50% | Upgrade |
Free Cash Flow | -55.32 | 3.38 | 114.06 | -12.38 | 42.22 | Upgrade |
Free Cash Flow Per Share | -0.09 | 0.01 | 0.19 | -0.02 | 0.09 | Upgrade |
Dividend Per Share | - | - | - | 0.014 | - | Upgrade |
Gross Margin | 25.79% | 30.28% | 42.73% | 43.92% | 44.34% | Upgrade |
Operating Margin | 11.13% | 19.87% | 32.30% | 31.51% | 33.91% | Upgrade |
Profit Margin | 4.52% | 14.18% | 21.98% | 22.67% | 20.60% | Upgrade |
Free Cash Flow Margin | -25.84% | 0.98% | 28.54% | -3.43% | 13.68% | Upgrade |
EBITDA | 32.88 | 74.36 | 134.21 | 115.8 | 106.2 | Upgrade |
EBITDA Margin | 15.36% | 21.61% | 33.58% | 32.10% | 34.40% | Upgrade |
D&A For EBITDA | 9.05 | 6 | 5.11 | 2.16 | 1.51 | Upgrade |
EBIT | 23.83 | 68.37 | 129.1 | 113.64 | 104.69 | Upgrade |
EBIT Margin | 11.13% | 19.87% | 32.30% | 31.51% | 33.91% | Upgrade |
Effective Tax Rate | 34.75% | 28.56% | 29.35% | 28.41% | 29.73% | Upgrade |
Advertising Expenses | 15.91 | 15.91 | 15.91 | 13.07 | 3.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.